Firstly if ANP goes to $5.00 , I ll die of heart attack...lol
Anyways MD suggested about big pivotal trial in one of the presos if I remember correct, hence cant rule that out..
Good luck all, not sure what may happen next week but very very exciting time coming up a I am desperately waiting for EMA progress along with overdue Other indications..
Obviously FDA minutes are coming first. Also regarding the Non clinical issues ...below is what I found on Google..
Nonclinical laboratory study means in vivo or in vitro experiments in which test articles are studied prospectively in test systems under laboratory conditions to determine their safety. The term does not include studies utilizing human subjects or clinical studies or field trials in animals..
So obviously the issue might be dose size, numbers , Finance etc..
As Dr Gil said they need to be on common ground, wouldn't be hard with the above issues or any other ones...
I think FDA is a big YES ...
Anyone here with any other non clinical info that is relevant?
IMO
GL all..
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-65
-
- There are more pages in this discussion • 1,032 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 7.9¢ | $33.53K | 416.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 92000 | 7.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 65186 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 92000 | 0.079 |
2 | 212658 | 0.078 |
1 | 200000 | 0.077 |
2 | 66500 | 0.076 |
4 | 206988 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 65186 | 3 |
0.082 | 97561 | 1 |
0.083 | 214000 | 1 |
0.084 | 161142 | 2 |
0.085 | 141000 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online